Recent Finacing
Recent Raise
Diag-Nose.io builds a platform combining machine learning and advanced proteomics to analyze nasal liquid biopsies collected with the ABEL Microsampler, enabling biomarker-based respiratory diagnostics and therapy matching.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
